SIRT1 and hepatocellular carcinoma: SIRT1 expression is correlated with an unfavorable prognosis in patients with HCC (Hao et al., 2014; Serrano-Gomez et al., 2016), suggesting a potential therapeutic use for selective SIRT1-targeting drugs.